News

Filter

Current filters:

Galderma

1 to 9 of 13 results

Ipsen and Galderma expand neurotoxins partnership

Ipsen and Galderma expand neurotoxins partnership

11-07-2014

French drugmaker Ipsen and global dermatology and skin health company Galderma have expanded the scope…

Botulinum toxinDermatologicalsGaldermaGalderma InternationalIpsen

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

28-05-2014

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into an agreement to…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceuticalValeant Pharmaceuticals

Nestle takes full control of Galderma Pharma

19-02-2014

The boards of Switzerland-based Nestle, the world’s largest food company, and French cosmetics firm…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceutical

Galderma drug is first FDA-approved facial erythema of rosacea treatment

27-08-2013

Switzerland-headquartered Galderma Laboratories says that the US Food and Drug Administration has approved…

brimonidineDermatologicalsGaldermaMirvasoNorth AmericaPharmaceuticalRegulation

News briefs on Ipsen/Galderma and YM BioSciences nimotuzumab assets

04-12-2012

French drugmaker Ipsen (Euronext: IPN) and Switzerland-headquartered Galderma have expanded their collaboration…

Asia-PacificBiotechnologyCIMABDysportGaldermaInnoKeys PTEIpsenLicensingnimotuzumabOncologyPharmaceuticalSouth AmericaYM Biosciences

1 to 9 of 13 results

COMPANY SPOTLIGHT

Menarini

Back to top